Lenzetto (estradiol spray for menopause) launched in the UK

This new hormonal therapy is applied to the skin and is specifically designed for use in women at least six months since last menses or surgical menopause, with or without a uterus. In clinical studies, adverse events were comparable to other transdermal products.